デフォルト表紙
市場調査レポート
商品コード
1440015

ポリメラーゼ連鎖反応(PCR)- 世界市場の考察、競合情勢、市場予測(2030年)

Polymerase Chain Reaction - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
ポリメラーゼ連鎖反応(PCR)- 世界市場の考察、競合情勢、市場予測(2030年)
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポリメラーゼ連鎖反応(PCR)の市場規模は、2023年に49億米ドル、2030年までに80億4,000万米ドルに達し、2024年~2030年の予測期間にCAGRで8.66%の成長が見込まれます。市場は、病原体によって引き起こされる疾患の有病率の上昇、臨床診断の分野での利用の増加、さらにその精度を高めるための新技術の進歩などの要因により、収益が増加する見込みであり、予測期間(2024年~2030年)に市場の大幅な収益成長がもたらされると予測されます。

ポリメラーゼ連鎖反応(PCR)の市場力学

ポリメラーゼ連鎖反応(PCR)市場の注目すべき促進要因の1つは、臨床診断の分野でのPCR技術の使用の増加です。COVID-19パンデミックにおけるSARS-CoVの存在を検出する方法としてのリアルタイムRT-PCR技術の使用は、医療産業にとって有益であることが証明されています。世界保健機関(2019)によれば、RT-PCR法はSARSCOVID-19の検出に向けたゴールデンスタンダードです。例えば、世界保健機関(2023)のレポートによると、世界中で5億4,092万3,532例のCOVID-19が確認されており、すべての症例がRT-PCR検査の使用によって検出されています。RT-PCR法の使用に関連する主な理由は、その高い感度と特異性です。RT-PCR法はCOVID-19の検出にのみ適用できるだけでなく、がん細胞の検出に向け腫瘍学でも使用されています。例えば、Annals of Surgery(2019)によると、RT-PCRは大腸がんの症例における循環がん細胞の観察にもっとも有効な手法でした。

ポリメラーゼ連鎖反応(PCR)市場の成長をもたらすその他の大きな要因の1つが、遺伝性疾患の診断における使用の増加です。例えば、Swedish Agency for Health Technology Assessment and Assessment of Social Services(2019)によると、遺伝性疾患が疑われる症例の80%において、RT-PCR法が従来の診断法のほとんどに取って代わっています。ポリメラーゼ連鎖反応(PCR)市場の成長をもたらすもう1つの主な要因は、製品の有効性を向上させるためにPCR技術で行われている継続的な技術の進歩です。例えば、2020年12月、Stilla TechnologiesはCrystal Digital PCR(nacia multiplex PCR Mix、nacia PCR Mix)で最適な性能を発揮するPolymerase Chain Reaction Mix試薬ラインを発売しました。これらはデジタルPCR用途で優れた結果と堅牢性が得られるよう最適化されています。

同様の発展として、DNA/RNA分析のスペシャリストであるPCR Biosystemsは2022年3月、迅速で堅牢なDNAとRNA増幅に向けたIsoFast Bst Polymerase試薬セットを発売しました。しかし、代替療法の利用可能性や、ポリメラーゼ連鎖反応(PCR)機器と試薬の高いコストが、ポリメラーゼ連鎖反応(PCR)市場の成長抑制要因として作用する可能性があります。

ポリメラーゼ連鎖反応(PCR)市場は、COVID-19パンデミックによって市場が急成長した時期がありました。COVID-19パンデミックは、医療サービスの大規模な再編成と医療処置の実施をもたらし、世界保健機関(2019)によると、RT-PCR検査報告が感染検出の基準となっていました。ポリメラーゼ連鎖反応(PCR)市場に関与するすべての主要市場企業は、COVID-19のフェーズ中にその収益の力強い成長を経験しました。例えば、Thermo Fisher Scientific Corporationの年次レポート(2023)によると、同社の収益シェアは、2018年と比較して26%増の322億2,000万米ドルとなり、GAAP希薄化後EPSは74%増加しました。もう1つの例では、Qiagen Annual Report(2023)によると、Qiagenは2018年と比較して収益シェアが22.53%急増しました。世界のCOVID-19患者は減少していますが、それでもポリメラーゼ連鎖反応(PCR)に基づく検査は、臨床診断や研究における一定の用途のために増加傾向にあり、2024年~2030年の予測期間におけるポリメラーゼ連鎖反応(PCR)市場の成長を押し上げています。

当レポートでは、世界のポリメラーゼ連鎖反応(PCR)市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 ポリメラーゼ連鎖反応(PCR)市場レポートのイントロダクション

第2章 ポリメラーゼ連鎖反応(PCR)市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 ポリメラーゼ連鎖反応(PCR)市場の主な要因の分析

  • ポリメラーゼ連鎖反応(PCR)市場の促進要因
  • ポリメラーゼ連鎖反応(PCR)市場の抑制要因と課題
  • ポリメラーゼ連鎖反応(PCR)市場の機会

第5章 ポリメラーゼ連鎖反応(PCR)市場のポーターのファイブフォース分析

第6章 ポリメラーゼ連鎖反応(PCR)市場に対するCOVID-19の影響分析

第7章 ポリメラーゼ連鎖反応(PCR)市場のレイアウト

  • タイプ別
    • 従来式PCR
    • リアルタイムRT-PCR
    • デジタルPCR
    • その他
  • 用途別
    • 感染症
    • がん
    • 遺伝性疾患
  • エンドユーザー別
    • 病院、診療所
    • 学術・研究所
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 ポリメラーゼ連鎖反応(PCR)市場:世界の企業シェア分析 - 主要3~5社

第9章 ポリメラーゼ連鎖反応(PCR)市場の企業と製品のプロファイル

  • Thermo-Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen
  • Agilent Technologies, Inc.
  • Standard Biotools
  • F. Hoffmann-La Roche Ltd.
  • Eppendorf
  • Avance Biosciences Inc.
  • Merck & Co., Inc.
  • Abbott
  • Promega Corporation
  • Takara Bio Inc.
  • Endress+Hauser Group Services AG
  • BioMerieux
  • GenMark Diagnostics, Inc.
  • Grifols, S.A
  • Hologic, Inc.
  • BD
  • Sysmex Corporation
  • Stilla

第10章 KOLの見解

第11章 プロジェクトアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Polymerase Chain Reaction Market
  • Table 3: Polymerase Chain Reaction Market in Global (2021-2030)
  • Table 4: Polymerase Chain Reaction Market in Global by Type (2021-2030)
  • Table 5: Polymerase Chain Reaction Market in Global by Application(2021-2030)
  • Table 6: Polymerase Chain Reaction Market in Global by End User (2021-2030)
  • Table 7: Polymerase Chain Reaction Market in Global by Geography (2021-2030)
  • Table 8: Polymerase Chain Reaction Market in North America (2021-2030)
  • Table 9: Polymerase Chain Reaction Market in North America by Country (2021-2030)
  • Table 10: Polymerase Chain Reaction Market in the US (2021-2030)
  • Table 11: Polymerase Chain Reaction Market in Canada (2021-2030)
  • Table 12: Polymerase Chain Reaction Market in Mexico (2021-2030)
  • Table 13: Polymerase Chain Reaction Market in Europe (2021-2030)
  • Table 14: Polymerase Chain Reaction Market in Europe by Country (2021-2030)
  • Table 15: Polymerase Chain Reaction Market in France (2021-2030)
  • Table 16: Polymerase Chain Reaction Market in Germany (2021-2030)
  • Table 17: Polymerase Chain Reaction Market in the United Kingdom (2021-2030)
  • Table 18: Polymerase Chain Reaction Market in Italy (2021-2030)
  • Table 19: Polymerase Chain Reaction Market in Spain (2021-2030)
  • Table 20: Polymerase Chain Reaction Market in Russia (2021-2030)
  • Table 21: Polymerase Chain Reaction Market in Rest of Europe (2021-2030)
  • Table 22: Polymerase Chain Reaction Market in APAC (2021-2030)
  • Table 23: Polymerase Chain Reaction Market in APAC by Country (2021-2030)
  • Table 24: Polymerase Chain Reaction Market in China (2021-2030)
  • Table 25: Polymerase Chain Reaction Market in Japan (2021-2030)
  • Table 26: Polymerase Chain Reaction Market in India (2021-2030)
  • Table 27: Polymerase Chain Reaction Market in Australia (2021-2030)
  • Table 28: Polymerase Chain Reaction Market in South Korea (2021-2030)
  • Table 29: Polymerase Chain Reaction Market in Rest of APAC (2021-2030)
  • Table 30: Polymerase Chain Reaction Market in Rest of World (2021-2030)
  • Table 31: Polymerase Chain Reaction Market in RoW by Region (2021-2030)
  • Table 32: Polymerase Chain Reaction Market in Middle East (2021-2030)
  • Table 33: Polymerase Chain Reaction Market in Africa (2021-2030)
  • Table 34: Polymerase Chain Reaction Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Polymerase Chain Reaction Market
  • Figure 3: Polymerase Chain Reaction Market in Global (2021-2030)
  • Figure 4: Polymerase Chain Reaction Market in Global by Type (2021-2030)
  • Figure 5: Polymerase Chain Reaction Market in Global by Application(2021-2030)
  • Figure 6: Polymerase Chain Reaction Market in Global by End User (2021-2030)
  • Figure 7: Polymerase Chain Reaction Market in Global by Geography (2021-2030)
  • Figure 8: Polymerase Chain Reaction Market in North America (2021-2030)
  • Figure 9: Polymerase Chain Reaction Market in North America by Country (2021-2030)
  • Figure 10: Polymerase Chain Reaction Market in the US (2021-2030)
  • Figure 11: Polymerase Chain Reaction Market in Canada (2021-2030)
  • Figure 12: Polymerase Chain Reaction Market in Mexico (2021-2030)
  • Figure 13: Polymerase Chain Reaction Market in Europe (2021-2030)
  • Figure 14: Polymerase Chain Reaction Market in Europe by Country (2021-2030)
  • Figure 15: Polymerase Chain Reaction Market in France (2021-2030)
  • Figure 16: Polymerase Chain Reaction Market in Germany (2021-2030)
  • Figure 17: Polymerase Chain Reaction Market in the United Kingdom (2021-2030)
  • Figure 18: Polymerase Chain Reaction Market in Italy (2021-2030)
  • Figure 19: Polymerase Chain Reaction Market in Spain (2021-2030)
  • Figure 20: Polymerase Chain Reaction Market in Russia (2021-2030)
  • Figure 21: Polymerase Chain Reaction Market in Rest of Europe (2021-2030)
  • Figure 22: Polymerase Chain Reaction Market in APAC (2021-2030)
  • Figure 23: Polymerase Chain Reaction Market in APAC by Country (2021-2030)
  • Figure 24: Polymerase Chain Reaction Market in China (2021-2030)
  • Figure 25: Polymerase Chain Reaction Market in Japan (2021-2030)
  • Figure 26: Polymerase Chain Reaction Market in India (2021-2030)
  • Figure 27: Polymerase Chain Reaction Market in Australia (2021-2030)
  • Figure 28: Polymerase Chain Reaction Market in South Korea (2021-2030)
  • Figure 29: Polymerase Chain Reaction Market in Rest of APAC (2021-2030)
  • Figure 30: Polymerase Chain Reaction Market in Rest of World (2021-2030)
  • Figure 31: Polymerase Chain Reaction Market in RoW by Region (2021-2030)
  • Figure 32: Polymerase Chain Reaction Market in Middle East (2021-2030)
  • Figure 33: Polymerase Chain Reaction Market in Africa (2021-2030)
  • Figure 34: Polymerase Chain Reaction Market in South America (2021-2030)
  • Figure 35: Polymerase Chain Reaction Market Drivers
  • Figure 36: Polymerase Chain Reaction Market Barriers
  • Figure 37: Polymerase Chain Reaction Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis
目次
Product Code: DISR0053

Polymerase Chain Reaction Market By Type (Conventional PCR, Real-Time RT-PCR, Digital PCR, Others) By Application (Infectious Diseases, Cancer, Hereditary Disorders, And Others), By End-User (Hospitals & Clinics, Academic & Research Labs, Others) and by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to rise in the prevalence of infectious diseases, increased applications in clinical diagnostics, and constant advancements in pcr technology for efficient use in biomedical sciences.

The Global Polymerase Chain Reaction market was valued at USD 4.90 billion in 2023, growing at a CAGR of 8.66% during the forecast period from 2024 to 2030 to reach USD 8.04 billion by 2030. The Polymerase Chain Reaction market is slated to witness increasing revenue owing to factors such as a rise in the prevalence of diseases caused by pathogens, increasing applications in the field of clinical diagnostics, along with latest technological advancements to further enhance its accuracy is expected to result in appreciable revenue growth in the Polymerase Chain Reaction market during the forecast period (2024-2030).

Polymerase Chain Reaction Market Dynamics:

One of the noteworthy drivers of the Polymerase Chain Reaction market is the increasing use of PCR techniques in the clinical diagnostics sector. The use of the real-time RT-PCR technique as a way to detect the presence of SARS-CoV during the COVID-19 pandemic has proved to be a boon for the healthcare industry. According to the World Health Organization (2019), the RT-PCR technique is the golden standard for the detection of SARS coronavirus. For instance, as per reports from World Health Organization (2023), there have been 540,923,532 confirmed cases of Covid-19 worldwide, and every case was detected through the use of an RT-PCR test. The main reasons associated with the use of the RT-PCR technique are its high sensitivity and specificity. Not only is the RT-PCR solely applicable for the detection of COVID-19, but it is also used in oncology for the detection of cancer cells. For example, according to the Annals of Surgery (2019), RT-PCR was the most effective technique for the observation of circulating cancer cells in cases of colorectal cancer.

One of the other prominent factors responsible for the growth of the Polymerase Chain Reaction Market is its increasing use in the diagnosis of genetic disorders. For example, according to the Swedish Agency for Health Technology Assessment and Assessment of Social Services (2019), the RT-PCR technique has replaced most of the conventional diagnostic methods in 80% of suspected cases of genetic disorders. Another key factor responsible for the growth of the Polymerase Chain Reaction market is the continuous technological advancements taking place in PCR technology to improve product efficacy. For instance, in December 2020, Stilla Technologies launched a Polymerase Chain Reaction Mix reagent line for optimal performance with Crystal Digital PCR (nacia multiplex PCR Mix and nacia PCR Mix), which are optimized for better results and robustness for digital PCR applications.

In a similar development, in March 2022, PCR Biosystems, specialists in DNA and RNA analysis launched a set of IsoFast Bst Polymerase reagents for rapid, robust DNA & RNA amplification. However, the availability of alternative therapies and the high cost of the Polymerase Chain Reaction machine and reagents may act as restraining factors to the Polymerase Chain Reaction market growth.

The Polymerase Chain Reaction market reported a period of rapid market growth due to the COVID-19 pandemic. The COVID-19 pandemic resulted in the massive reorganization of the healthcare services and carrying out of medical procedures, where the RT-PCR test reports were the measure for the detection of infection, as per the World Health Organization (2019). All the key market players involved in the Polymerase Chain Reaction Market experienced robust growth in their revenue during the phases of COVID-19. For example, according to the annual report of Thermo Fisher Scientific Corporation (2023), the revenue share of the company increased by 26% to 32.22 billion USD, and the GAAP diluted EPS increased by 74%, as compared to 2018. In another instance, according to the Qiagen Annual Report (2023), Qiagen saw a jump in its revenue share by 22.53% as compared to 2018. Although the global COVID-19 cases reducing, still Polymerase Chain Reaction based test is on the rise because of their constant applications in clinical diagnostics and research, which is uplifting the Polymerase Chain Reaction market growth during the forecast period from 2024-2030.

Polymerase Chain Reaction Market Segment Analysis:

Polymerase Chain Reaction Market by Type (Conventional PCR, Real-time RT-PCR, Digital PCR, and Others), Application (Infectious diseases, Cancer, Hereditary disorders, and Others), End-user (Hospitals & Clinics, Academic & Research Labs, Others), Geography (North-America, Europe, Asia-Pacific, Rest of the World)

Based on the Application segment of the Polymerase Chain Reaction Market, the infectious diseases category is projected to register significant growth in revenue in the Polymerase Chain Reaction market during the forecast period (2024-2030). This can be ascribed to the increasing prevalence of infectious diseases caused by viruses, bacteria, fungi, and other pathogens. With one of the most infectious and recent examples of infectious disease being COVID-19, other hazardous diseases caused by pathogens are HIV AIDS, and Tuberculosis, caused by viruses and bacteria respectively. As per reports from World Health Organization (2023), there were 37.7 billion cases of HIV-AIDS globally, by the end of 2020.

The RT-PCR technique is regarded as the alternative gold standard for the detection of HIV AIDS. In cases of bacterial infection diseases like Tuberculosis, the RT-PCR technique shows high sensitivity and specificity during diagnosis. The RT-PCR technique also has its advantages in oncological studies. As per reports from World Health Organization (2023) cancer accounted for approximately 10 million deaths, in the year 2020. According to the same source, one of the primary reasons for cancer deaths was the late diagnosis of the disease, to which the Polymerase Chain Reaction appears to be the fastest and most sensitive test for the detection of tumors.

Therefore, considering the growing demand for this product type, numerous new products are being launched in the market with technological advancements. For example, in March 2022, MatMa Corporation launched MYRTA, a new hand-held Real-Time RT-PCR device for Point-of-Care (POC) and Over-the-Counter (OTC) molecular diagnostics.

Thus, considering the rising prevalence of various infectious diseases and their growing popularity among end users, the application segment is expected to generate considerable revenue thereby pushing the overall growth of the global Polymerase Chain Reaction market during the forecast period.

North America is expected to dominate the overall Polymerase Chain Reaction Market:

Among all the regions, North America is expected to lead in revenue generation in the global Polymerase Chain Reaction market. This can be ascribed to the growing prevalence of infectious diseases and the increasing number of clinical research studies in the North American region. According to the Centre for Disease Prevention and Control (2023), 6 in 10 people in the United States were burdened with a chronic disease, and 4 in 10 people had two or more diseases in the year 2023. The World Health Organization (2023) statistics show that the COVID-19 pandemic has severly impacted the U.S., with 88,932,987 cases and 1,018,035 deaths, by July 14, 2022. Due to such a high prevalence of infectious diseases in the United States, it expands the way for more amount of clinical studies and the latest diagnostic technological developments.

One of the other prominent factors supporting the growth of the North America Polymerase Chain Reaction market is the rising case of genetic disorders in the North American region. As per reports from the Centre for Disease Control and Prevention (2023), millions of people are affected by inherited genetic disorders such as cystic fibrosis, sickle-cell anemia, Lynch syndrome, etc. every year. Some genetic disorders are not diagnosed at birth but lead to severe consequences at a later stage due to late detection of the syndrome. For example, the report from the World Health Organization, Regional Office for the Eastern Mediterranean (2023), shows that cases with genetic disorders account for 2%-5% of all live births, 30% of the affected account for hospital admissions at a later stage, and 50% account for deaths during childhood in the year 2020, in industrialized countries.

The presence of a large patient population base in the North American region, also opens up the way for new technologies and collaborations to take place in clinical diagnostics areas. For example, in June 2022, Bio-Rad collaborated with Seegene Inc. for the production of molecular diagnostic products related to infectious diseases. Through this collaboration, Seegene started to provide diagnostic tests for use on Bio-Rad's LFX960x Real-Time PCR System for commercial use in the U.S. market. In another instance, according to the American Chemical Society (2023), researchers devised a postage stamp-sized polydimethylsiloxane chip with microchambers arrays in the PCR. Although the amplification efficiency of the chip-encoded PCR was 91% as compared to 98% in standard PCR, the chip-encoded PCR takes approximately 5 minutes for detection as compared to an hour in conventional PCRs. The source further stated that the technique will get commercialized in the future and could be used for rapid detection diagnosis during severe cases of pandemics.

Therefore, the presence of a large patient population base with infectious diseases and genetic disorders, coupled with a rise in technological advancements and clinical research studies is expected to bolster the growth of the Polymerase Chain Reaction market in the North American region during the forecast period.

Polymerase Chain Reaction Market Key Players:

Some of the key market players operating in the Polymerase Chain Reaction market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen, Agilent Technologies Inc., Standard Biotools, F. Hoffmann-La Roche Ltd., Eppendorf, Avance Biosciences Inc., Merck & Co. Inc., Abbott, Promega Corporation, Takara Bio Inc., Endress+Hauser Group Services AG, BioMerieux, GenMark Diagnostics Inc., Grifols SA, Hologic Inc., BD, Sysmex Corporation, Stilla, and others.

Recent Developmental Activities in the Polymerase Chain Reaction Market:

In January 2022, Qiagen collaborated with Atila Biosystems and Actome GmbH for the use of QIAcuity digital PCR instruments. Atila Biosystems will provide non-invasive prenatal testing and Actome extends QIAcuity reach from genomics to proteomics.

In June 2022, Bio-Rad collaborated with Seegene Inc., for the production of molecular diagnostic products related to infectious diseases. Through this, Seegene shall provide diagnostic tests in U.S markets for use on Bio-Rad's LFX960x real-time PCR system.

In March 2022, MatMa Corporation launched MYRTA, a new hand-held PCR device for POC & OTC Molecular Diagnostics.

Key Takeaways from the Polymerase Chain Reaction Market Report Study

  • Market size analysis for current Polymerase Chain Reaction market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the polymerase chain reaction market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for last 3 years.
  • Key companies dominating the global Polymerase Chain Reaction market.
  • Various opportunities available for the other competitor in the Polymerase Chain Reaction market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Polymerase Chain Reaction market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Polymerase Chain Reaction market growth in the coming future?

Target Audience who can be benefited from this Polymerase Chain Reaction Market Report Study

  • Polymerase Chain Reaction providers
  • Research organizations and consulting companies
  • Polymerase Chain Reaction -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Polymerase Chain Reaction machines and reagents
  • Various end users who want to know more about the Polymerase Chain Reaction market and latest technological developments in the Polymerase Chain Reaction market.

Frequently Asked Questions for Polymerase Chain Reaction Market:

1. What is Polymerase Chain Reaction?

Polymerase Chain Reaction is a laboratory technique based on the enzymatic replication of DNA. Short strands of DNA are amplified using enzymes that are primer-mediated. Through this, million to billion copies of DNA can be produced, leading to better observation and conduct of research studies.

2. What is the market for Global Polymerase Chain Reaction?

The Global Polymerase Chain Reaction market was valued at USD 4.90 billion in 2023, growing at a CAGR of 8.66% during the forecast period from 2024 to 2030 to reach USD 8.04 billion by 2030.

3. What are the drivers for Global Polymerase Chain Reaction market?

The Polymerase Chain Reaction Market is expected to grow significantly owing to factors such as a rise in the prevalence of diseases caused by pathogens and increasing applications in the field of clinical diagnostics. The rapidly growing technological advancements taking place in the Polymerase Chain Reaction market with better technologies for delivering precise results in a quick time are further expected to result in appreciable revenue growth in the Polymerase Chain Reaction market during the given forecast period (2024-2030).

4. Who are the key players operating in the Global Polymerase Chain Reaction Market?

Some of the key market players operating in the Polymerase Chain Reaction market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen, Agilent Technologies Inc., Standard Biotools, F. Hoffmann-La Roche Ltd., Eppendorf, Avance Biosciences Inc., Merck & Co. Inc., Abbott, Promega Corporation, Takara Bio Inc., Endress+Hauser Group Services AG, BioMerieux, GenMark Diagnostics Inc., Grifols SA, Hologic Inc., BD, Sysmex Corporation, Stilla, and others.

5. Which region has the highest share in the Polymerase Chain Reaction market?

North America is expected to dominate the overall Polymerase Chain Reaction market during the forecast period, 2024 to 2030. This can be ascribed to the presence of a huge number of cases of infectious diseases and genetic disorders in the North American region, leading to more diagnostic procedures. In addition, it is a highly potent market in terms of technological developments and new product launches along with the presence of key market players among other factors in the region.

Table of Contents

1.Polymerase Chain Reaction Market Report Introduction

2.Polymerase Chain Reaction Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Polymerase Chain Reaction Market Key Factors Analysis

  • 4.1. Polymerase Chain Reaction Market Drivers
    • 4.1.1. Rising demand for clinical diagnostics
    • 4.1.2. Increased applications in drug development and medicine
    • 4.1.3. Advancements in PCR Technology for more precise results
  • 4.2. Polymerase Chain Reaction Market Restraints and Challenges
    • 4.2.1. High cost of PCR machines
    • 4.2.2. Alternatives to PCR technology
  • 4.3. Polymerase Chain Reaction Market Opportunities
    • 4.3.1. Improving Product Technology and accuracy

5. Polymerase Chain Reaction Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Polymerase Chain Reaction Market

7. Polymerase Chain Reaction Market Layout

  • 7.1. By Type:
    • 7.1.1. Conventional PCR
    • 7.1.2. Real-time RT-PCR
    • 7.1.3. Digital PCR
    • 7.1.4. Others
  • 7.2. By Application:
    • 7.2.1. Infectious Diseases
    • 7.2.2. Cancer
    • 7.2.3. Hereditary Disorders
    • 7.2.4. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals and Clinics
    • 7.3.2. Academic & Research Labs
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.1.2. Canada Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.1.3. Mexico Polymerase Chain Reaction Market in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.2. Germany Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.4. Italy Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.5. Spain Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.6. Russia Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.7. Rest of Europe Polymerase Chain Reaction Market in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.2. Japan Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.3. India Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.4. Australia Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.5. South Korea Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia Pacific Polymerase Chain Reaction Market in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.4.2 Africa Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.4.3 South America Polymerase Chain Reaction Market in USD million (2021-2030)

8. Polymerase Chain Reaction Market Global Company Share Analysis - Key 3-5 Companies

9. Polymerase Chain Reaction Market Company and Product Profiles

  • 9.1. Thermo-Fisher Scientific Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Bio-Rad Laboratories, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Qiagen
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Agilent Technologies, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Standard Biotools
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. F. Hoffmann-La Roche Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Eppendorf
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Avance Biosciences Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Merck & Co., Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Abbott
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Promega Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Takara Bio Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Endress+Hauser Group Services AG
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. BioMerieux
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. GenMark Diagnostics, Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Grifols, S.A
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Hologic, Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. BD
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Sysmex Corporation
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Stilla
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us